Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
2 Mar 2010
UCB: Solid foundation for sustainable growth
Read More
29 Jan 2010
UCB accelerates transition to become patient-centric global biopharmaceutical leader with decision to exit the primary care market in the U.S.
Read More
21 Dec 2009
UCB announces initial clinical trial results involving patients taking certolizumab pegol for moderate to severe Crohn's disease
Read More
15 Dec 2009
UCB signs a new EUR 1.5 billion credit facility
Read More
3 Dec 2009
UCB completes the placement of 7-year bonds
Read More
3 Dec 2009
UCB launches offering of 7-year bonds
Read More
10 Nov 2009
Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
Read More
6 Nov 2009
UCB Extraordinary General Meeting
Read More
27 Oct 2009
UCB successfully completes its fixed rate bonds - Early termination of the offer period - Total amount is set at EUR 750 million
Read More
23 Oct 2009
UCB to offer a minimum of EUR 150 million[1] in 5-year fixed rate bonds
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
81
Page
82
Page
83
Page
84
Current page
85
Page
86
Page
87
Page
88
Page
89
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss